DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China flag China · Delayed Price · Currency is CNY
19.22
-0.28 (-1.44%)
Feb 13, 2026, 3:00 PM CST

SHA:603233 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
21,88917,15128,35937,58533,30751,603
Market Cap Growth
41.32%-39.52%-24.55%12.85%-35.46%89.92%
Enterprise Value
22,47920,00631,25140,04435,73249,307
Last Close Price
19.2214.4923.0129.9226.1240.01
PE Ratio
19.0018.7524.3136.2942.1048.58
Forward PE
17.4716.4423.7631.3728.0649.98
PS Ratio
0.820.651.161.771.993.54
PB Ratio
2.582.113.585.485.619.26
P/TBV Ratio
12.6012.2014.6111.7111.9014.49
P/FCF Ratio
5.5810.5220.5913.81128.0844.42
P/OCF Ratio
5.065.528.9410.0121.4226.41
PEG Ratio
1.030.451.131.051.44-
EV/Sales Ratio
0.840.761.271.892.133.38
EV/EBITDA Ratio
6.366.399.6322.1527.3632.16
EV/EBIT Ratio
12.1512.9317.4025.1832.4536.19
EV/FCF Ratio
5.7312.2722.6914.71137.4142.45
Debt / Equity Ratio
0.700.950.820.860.890.25
Debt / EBITDA Ratio
1.682.472.012.062.340.91
Debt / FCF Ratio
1.524.754.732.1820.291.21
Asset Turnover
1.031.051.091.111.131.39
Inventory Turnover
4.264.193.923.533.293.80
Quick Ratio
0.620.580.540.620.550.93
Current Ratio
0.960.920.941.101.101.52
Return on Equity (ROE)
14.75%12.20%16.63%16.86%13.98%21.87%
Return on Assets (ROA)
4.45%3.83%4.99%5.21%4.64%8.11%
Return on Invested Capital (ROIC)
16.16%11.54%14.93%14.69%15.65%44.62%
Return on Capital Employed (ROCE)
14.50%12.20%14.20%14.30%10.80%19.90%
Earnings Yield
5.20%5.33%4.11%2.76%2.38%2.06%
FCF Yield
17.92%9.51%4.86%7.24%0.78%2.25%
Dividend Yield
3.54%4.28%1.35%1.67%1.33%1.16%
Payout Ratio
66.05%82.34%51.82%40.58%67.53%31.38%
Buyback Yield / Dilution
0.96%0.28%0.50%-0.69%0.24%-2.65%
Total Shareholder Return
4.45%4.56%1.84%0.98%1.57%-1.49%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.